bioAffinity Technologies shares are trading higher after the company announced it is presenting two posters highlighting CyPath Lung at the 2026 NAVREF Annual Conference.

Benzinga Newsdesk www.benzinga.com Positive 94.0%

Neg 0% Neu 0% Pos 94%

Comments

No comments yet. Be the first!